Publications by authors named "Sara Corral-Cativiela"
Pharmaceuticals (Basel)
November 2023
Article Synopsis
- Conventional therapy for Crohn's disease (CD) often fails to control symptoms, leading to a rise in the use of biologic drugs.
- This study systematically reviewed phase 2 and 3 clinical trials from 2018 to 2023, focusing on the efficacy and safety of eight biologic drugs in adults with moderate-severe CD.
- Results showed that most biologic drugs were effective and well-tolerated, with mild adverse effects, making them a viable option for patients who don't respond adequately to traditional treatments.
